Michaela R. Reagan
- Molecular Biology top 5%
- Oncology top 2%
- Hematology top 1%
- Cancer Research top 2%
- Biomaterials top 2%
- Co-authors
- David L. KaplanCarolyne FalankIrene M. GhobrialHeather FairfieldXiaohui ZhangClifford J. RosenAldo M. RoccaroAntonio Sacco
- Topics
- Multiple Myeloma Research and Treatments (41 papers)Chemokine receptors and signaling (18 papers)Mesenchymal stem cell research (15 papers)
- Cited by
- HematologyCancer ResearchGenetics
- Journals
- Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Michaela R. Reagan
89 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.9k
- Oncology 1.1k
- Hematology 1.1k
- Cancer Research 883
- Biomaterials 619
Countries citing papers authored by Michaela R. Reagan
This map shows the geographic impact of Michaela R. Reagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela R. Reagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela R. Reagan more than expected).
Fields of papers citing papers by Michaela R. Reagan
This network shows the impact of papers produced by Michaela R. Reagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela R. Reagan. The network helps show where Michaela R. Reagan may publish in the future.
Co-authorship network of co-authors of Michaela R. Reagan
This figure shows the co-authorship network connecting the top 25 collaborators of Michaela R. Reagan. A scholar is included among the top collaborators of Michaela R. Reagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela R. Reagan. Michaela R. Reagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 15 | |
| 5 | 12 | |
| 6 | 32 | |
| 7 | 15 | |
| 8 | 26 | |
| 9 | 22 | |
| 10 | 70 | |
| 11 | 33 | |
| 12 | 53 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 10 | |
| 16 | 23 | |
| 17 | 64 | |
| 18 | 15 | |
| 19 | 152 | |
| 20 | 16 |
About Michaela R. Reagan
Michaela R. Reagan is a scholar working on Hematology, Oncology and Genetics, having authored 91 papers that have together received 4.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Chemokine receptors and signaling (18 papers) and Mesenchymal stem cell research (15 papers). The work is most often cited by research in Hematology (1.1k citations), Cancer Research (883 citations) and Genetics (618 citations). Michaela R. Reagan has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include David L. Kaplan, Carolyne Falank, Irene M. Ghobrial, Heather Fairfield, Xiaohui Zhang, Clifford J. Rosen, Aldo M. Roccaro, Antonio Sacco, Feda Azab and Samantha Costa. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.